Peldesine

DB02568InvestigationalSmall molecule

Peldesine is a potent inhibitor of human CCRF-CEM T-cell proliferation. It has undergone phase I trials for the treatment of Human Immunodeficiency Virus (HIV) infections.

Formula / weight: C₁₂H₁₁N₅O · 241.2486 g/mol (avg)
Code names: BCX-34

Resolves to

Compound

UNII7B646RJ70FCAS133432-71-0ChEMBLCHEMBL311300PubChem60817

Structure

InChIKeyDOHVAKFYAHLCJP-UHFFFAOYSA-NSMILESNC1=NC(=O)C2=C(N1)C(CC1=CN=CC=C1)=CN2

Targets

P00491PNP

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

607Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Peldesine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account